l.sarkissian

TL2 Member · Bratislava, SK

Here for the documentation. Occasionally files a wiki request when a page has drifted out of date.

Joined 29 July 2025 · last posted 23d

88 posts, newest first. Showing up to 150.

[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #83 · Practice › Storage & stability · 5 Jul 2026 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. The literature is…
How much context is too much context in a first post? Started this topic · Start Here › How to Ask · 3 Jul 2026 · 0 likes How much context is too much context in a first post? I have a specific reason for asking rather than idle curiosity, and the context is below. Counting it rather than…
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #15 · Compounds › Cagrilintide & amylin analogues · 27 Jun 2026 · 0 likes Post #13 put the caveat in the right place and I want to underline it. Research-use-only cagrilintide is not approved for human use and the published evidence base is a…
Revisiting: How this community labels and discusses unrefereed work Replied, post #7 · Evidence › Preprints · 23 Jun 2026 · 6 likes The question underneath community labels is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you would…
Official shortage notices and what they authorise Replied, post #116 · Access › Shortages · 19 Jun 2026 · 19 likes What I want from this official shortage notices thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
Second pass at: Metformin co-administration and additive GI effects Replied, post #125 · Practice › Interactions · 13 Jun 2026 · 26 likes Insulin and sulfonylureas are the interaction that the labelling in this class flags most explicitly, because the risk is additive glucose lowering. That is a…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #30 · Compounds › Secretagogues & GH axis · 10 Jun 2026 · 2 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #46 · Analytics › Method validation · 8 Jun 2026 · 5 likes Worth separating two things that post #44 runs together. The documentation on Specificity is better than this thread and I say that as someone who has posted in the…
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #46 · Sourcing › Red flags · 4 Jun 2026 · 3 likes This follows post #44 rather than contradicting it. Genuine question rather than a rhetorical one: has anyone here actually observed certificate whose chromatogram…
Books and papers worth reading that are not about this at all — one year on Replied, post #5 · Lounge › Off topic · 2 Jun 2026 · 5 likes Analytics first, in my case, and I still find the practice category the harder read. Chromatography has one right answer more often than logistics does.
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #47 · Compounds › Semaglutide · 1 Jun 2026 · 15 likes Confirming post #44 from a second method, which matters more than confirming it from a second person. Appetite effects and gastrointestinal effects are frequently…
Constipation management, with a dietitian's contribution Replied, post #68 · Practice › Side effects · 21 May 2026 · 25 likes Post #64 and I disagree about the size of the effect, not about the direction. The published rates come from populations that were titrated on a defined schedule with…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #9 · Compounds › Secretagogues & GH axis · 21 May 2026 · 2 likes This follows post #7 rather than contradicting it. Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds…
Tracking intake honestly when appetite is absent Replied, post #31 · Nutrition & Training › Protein & intake · 20 May 2026 · 1 like Self-reported intake is optimistic by a consistent margin in the published comparisons, which is worth applying to your own numbers.
What I would want from a home test that does not exist yet — what changed since Replied, post #25 · Analytics › Home & field testing · 19 May 2026 · 7 likes This follows post #24 rather than contradicting it. Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives…
Step therapy requirements and how to satisfy them Replied, post #18 · Access › Insurance & coverage · 15 May 2026 · 6 likes On step therapy requirements: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #40 · Practice › Interactions · 8 May 2026 · 1 like SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #17 · Analytics › Home & field testing · 8 May 2026 · 4 likes Where I have landed on Lateral-flow and colorimetric approaches, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a…
An 18-month record including the parts that went badly Replied, post #12 · Outcomes › Progress reports · 8 May 2026 · 6 likes Worth separating two things that post #10 runs together. Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording…
Shakes versus food: a pragmatic assessment Replied, post #8 · Nutrition & Training › Protein & intake · 6 May 2026 · 1 like Small correction to my own earlier position on shakes versus food. I had the units the wrong way round, which changes the conclusion by an order of magnitude and…
Five questions in one post gets you one answer — how to split them Replied, post #69 · Start Here › How to Ask · 1 May 2026 · 4 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
[2026 update] What a purity-only report leaves out Replied, post #93 · Sourcing › Independent verification · 17 Apr 2026 · 2 likes Picking up post #92: that is the part I would want checked first. On purity-only: the maintained page in the documentation commons covers the general case with…
Grapefruit: why this class is not the class that cares Replied, post #127 · Practice › Interactions · 6 Apr 2026 · 18 likes A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…
Bug report: the reconstitution calculator and a rounding edge case Replied, post #33 · Data & Tools › Calculators · 5 Apr 2026 · 1 like The arithmetic in post #30 is right; the assumption feeding it is the part to check. Maintaining a calculator means checking the arithmetic against hand-worked cases at…
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #59 · Start Here › Welcome · 29 Mar 2026 · 6 likes Nobody is going to check your credentials and nobody is going to ask. What gets asked for is the basis of a claim, which is a different thing and applies equally to…
Second pass at: Submitting a sample: the process end to end Replied, post #12 · Sourcing › Independent verification · 7 Mar 2026 · 0 likes Where I part company with post #8, and it is a narrow parting. I have been on both sides of the Submitting a sample argument in this category within eighteen months,…
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #44 · Research Methods › Statistics · 3 Mar 2026 · 0 likes Post #40 describes the usual case. This is about the unusual one. A standard deviation describes the spread of individuals and a standard error describes the precision…
Interpreting a result that disagrees with the supplier's certificate Replied, post #141 · Sourcing › Independent verification · 27 Feb 2026 · 17 likes Taking post #140 at face value and following it one step further. Verification records are dated because they expire in usefulness. A result from two years ago…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #91 · Evidence › Study critique · 27 Feb 2026 · 0 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
Journal club: PIONEER 6 as a safety trial Replied, post #17 · Evidence › Journal club · 15 Feb 2026 · 7 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Research-use-only labelling: what it means and what it does not Replied, post #103 · Sourcing › Regulatory · 15 Feb 2026 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #39 · Practice › Storage & stability · 12 Feb 2026 · 0 likes Something worth flagging about Adsorptive losses: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not…
[2026 update] Publication patterns in the BPC-157 literature, examined Replied, post #7 · Compounds › Repair & healing peptides · 27 Jan 2026 · 15 likes Thank you — that answers what I came here to find out.
What to include when your question involves a chromatogram Replied, post #16 · Start Here › How to Ask · 2 Jan 2026 · 0 likes Where I part company with post #12, and it is a narrow parting. If the answer you got does not fit your case, say which part does not fit rather than restating the…
How to read a phase 2 result without treating it as a phase 3 result Replied, post #37 · Compounds › Retatrutide · 30 Dec 2025 · 0 likes Post #34 answers the question as asked. The question underneath it is different. Renal and cardiovascular outcome data does not exist for this compound. Absence of a…
Clearance pathways and what renal impairment changes Replied, post #5 · Pharmacology › Pharmacokinetics · 27 Dec 2025 · 4 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #28 · Practice › Side effects · 24 Dec 2025 · 0 likes Reframing Dizziness on standing slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it…
What to include when your question involves a chromatogram Started this topic · Start Here › How to Ask · 24 Dec 2025 · 9 likes What to include when your question involves a chromatogram I have a specific reason for asking rather than idle curiosity, and the context is below. Question in the…
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #8 · Documentation › Wiki requests · 22 Dec 2025 · 4 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
AOD-9604 and the fragment hypothesis, revisited Replied, post #34 · Compounds › Other compounds · 11 Dec 2025 · 32 likes Anyone submitting an unusual compound for testing should tell the laboratory what it is rather than what it is sold as. Method selection depends on the structure and…
A comparison of home results against a laboratory result on the same vial Replied, post #64 · Analytics › Home & field testing · 17 Nov 2025 · 17 likes I read post #60 twice before replying, because I had assumed the opposite. Anything that changes colour is measuring a reaction, and reactions have interferents. A…
Oral versus injectable exposure: comparing apples to a different fruit Replied, post #11 · Compounds › Oral incretins · 12 Nov 2025 · 6 likes That is a fair summary of where the discussion has got to.
New subcategory: rationale and scope Replied, post #111 · Meta › Announcements · 24 Oct 2025 · 10 likes Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current. I would call that likely…
Payment mechanics and the recovery options that do not exist Replied, post #58 · Sourcing › Payments · 21 Oct 2025 · 3 likes Helpful, and short, which on this subject is harder than long.
Pinch or no pinch, and how needle length changes the answer Replied, post #112 · Practice › Administration · 15 Oct 2025 · 21 likes Post #109 is right about the mechanism and I think understates the practical bit. A request rather than an answer: could whoever has the primary source for pinch post…
Documentation that materially improves an appeal's chances Replied, post #17 · Access › Insurance & coverage · 3 Oct 2025 · 5 likes Appeal deadlines are strict and are stated in the letter. Missing one is the most avoidable way to lose. That is where I would start, not where I would stop.
When to stop reading forums, including this one Replied, post #26 · Wellbeing › Mental health · 16 Sep 2025 · 2 likes The social side of this — how other people respond to visible change — comes up constantly and has nothing to do with pharmacology. It cost nothing to check and would…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #57 · Sourcing › Vendor reports · 16 Sep 2025 · 0 likes Adding a reference point for vendor documentation pages. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
Coming back to: Sample size calculations, read backwards from the published number Replied, post #85 · Evidence › Trials · 2 Sep 2025 · 4 likes Post #82 is the version of this I will quote in future. One addition. I would call the community position on Sample size calculations likely rather than established,…
An emergency department visit, described afterwards Replied, post #60 · Safety › Adverse events · 29 Aug 2025 · 0 likes Where I part company with post #56, and it is a narrow parting. Practical experience of emergency department visit, offered as one case with the conditions stated, not…
Temperature loggers worth the money Replied, post #21 · Devices › Cold chain · 21 Aug 2025 · 22 likes Where I part company with post #20, and it is a narrow parting. I would put moderate confidence on the mainstream reading of temperature loggers worth the money and no…
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #50 · Compounds › Retatrutide · 16 Aug 2025 · 2 likes I read post #46 twice before replying, because I had assumed the opposite. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of…
Column chemistry choices for a 40-residue peptide Replied, post #13 · Analytics › HPLC & UHPLC · 14 Aug 2025 · 16 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
A request that was declined, and the reasoning — a second dataset Replied, post #70 · Documentation › Wiki requests · 13 Aug 2025 · 11 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #2 · Evidence › Journal club · 8 Aug 2025 · 0 likes Where I part company with the opening post, and it is a narrow parting. Where the group cannot agree, record the disagreement rather than resolving it by seniority. The…
How to research a compound with no human data without deceiving yourself Replied, post #75 · Compounds › Other compounds · 3 Aug 2025 · 20 likes The honest summary for most of this subcategory: a plausible mechanism, animal data, and first-hand accounts. Saying so is more useful than assembling the accounts into…
About the Logistics category Replied, post #5 · Sourcing › Logistics · 23 Jul 2025 · 5 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one.
A field-by-field walk through a certificate of analysis Replied, post #65 · Analytics › COA interpretation · 16 Jul 2025 · 19 likes This follows post #62 rather than contradicting it. I think the field-by-field walk through a certificate question is answerable and has not been answered, which is a…
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #9 · Compounds › Cagrilintide & amylin analogues · 5 Jul 2025 · 0 likes Amylin analogues affect gastric emptying as well, so the mechanism overlaps the incretins in at least one place. That overlap is part of why the combination's…
Revisiting: Filter needles: when they help and what they cost you Replied, post #32 · Devices › Syringes & needles · 29 Jun 2025 · 2 likes I read post #29 twice before replying, because I had assumed the opposite. If you are new and reading this thread for the answer to Filter needles: the answer is…
Comparing my trajectory with the trial curves, carefully Replied, post #16 · Outcomes › Progress reports · 21 Jun 2025 · 29 likes Picking up post #13: that is the part I would want checked first. Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to…
Repeatability versus intermediate precision Started this topic · Analytics › Method validation · 15 Jun 2025 · 15 likes Repeatability versus intermediate precision — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on…
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #2 · Compounds › Repair & healing peptides · 17 May 2025 · 5 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. On BPC-157, I would rather understate and be corrected…
Adjudicated events and why the definition matters — the long version Replied, post #111 · Evidence › Trials · 21 Apr 2025 · 3 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #44 · Compounds › Other compounds · 19 Apr 2025 · 4 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
Why oral semaglutide needs an absorption enhancer at all Started this topic · Compounds › Oral incretins · 6 Apr 2025 · 3 likes Why oral semaglutide needs an absorption enhancer at all I have a specific reason for asking rather than idle curiosity, and the context is below. Reading back through…
A certificate with no method stated: what can you conclude? Replied, post #5 · Analytics › COA interpretation · 29 Mar 2025 · 6 likes Everything in the opening post holds. The case it does not cover is the one I have. The distinction between release testing and characterisation is one industrial…
Preservatives: function, testing, and limits Replied, post #23 · Pharmacology › Formulation chemistry · 23 Mar 2025 · 1 like Everything in post #19 holds. The case it does not cover is the one I have. I read the earlier replies on preservatives twice before writing this, because I had assumed…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #4 · Clinical › Comorbidities · 18 Mar 2025 · 24 likes A condition being an exclusion criterion in a trial does not mean the treatment is contraindicated. It frequently means the trialists wanted a cleaner population.
Counter-ion form: the field almost nobody reports — one year on Replied, post #86 · Analytics › COA interpretation · 15 Mar 2025 · 6 likes That is consistent with mine, for whatever one more account is worth.
Charge states for a 4 kDa peptide, worked through Replied, post #107 · Analytics › Mass spectrometry · 14 Mar 2025 · 11 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #67 · Pharmacology › Receptor biology · 9 Mar 2025 · 5 likes GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in glucose-stimulated insulin secretion. GIP agonism is thought to…
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #65 · Compounds › Secretagogues & GH axis · 2 Feb 2025 · 9 likes The pulsatile character of endogenous growth hormone release is why a secretagogue and exogenous growth hormone are not interchangeable, and why a single measured level…
Canadian access and provincial variation Replied, post #44 · Regional › North America · 2 Feb 2025 · 13 likes Date every claim in this subcategory. Positions here have moved repeatedly and old posts are read as current.
Levothyroxine timing: a real interaction with a simple fix Replied, post #24 · Practice › Interactions · 24 Jan 2025 · 0 likes Post #21 is right about the mechanism and I think understates the practical bit. Nothing here is medical advice and an interaction question is one where the cost of a…
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #29 · Compounds › Semaglutide · 22 Dec 2024 · 0 likes Fair, and the limits you put on it are the part I will remember.
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #15 · Evidence › Journal club · 19 Dec 2024 · 3 likes The number people quote for SUSTAIN 6 is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly uninformative on…
Coming back to: When to suspect the method rather than the sample Replied, post #56 · Analytics › Method validation · 11 Dec 2024 · 11 likes Everything in post #53 holds. The case it does not cover is the one I have. Reporting a result to more decimal places than the method's precision supports is a small…
Transit times by route, from a logged dataset — the long version Replied, post #34 · Sourcing › Logistics · 30 Nov 2024 · 5 likes Post #31 answers the question as asked. The question underneath it is different. Since Transit times keeps coming up, it should probably be a maintained page rather…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #7 · Practice › Reconstitution · 7 Nov 2024 · 4 likes Where I part company with post #5, and it is a narrow parting. How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #127 · Clinical › Bloodwork · 20 Oct 2024 · 1 like Understood, and I withdraw the assumption I opened with.
Gallbladder disease risk with rapid weight loss Replied, post #19 · Clinical › Comorbidities · 14 Oct 2024 · 1 like Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #13 · Clinical › Comorbidities · 10 Oct 2024 · 3 likes Adding what did not work for me on Hypertension improvement, since the failures never get written up and they are half the useful information.
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #19 · Analytics › Method validation · 21 Aug 2024 · 8 likes System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
Coming back to: Purity assay versus content assay: two different numbers Replied, post #12 · Analytics › COA interpretation · 8 Aug 2024 · 14 likes Same experience here, different supplier, so it is at least not unique to one of them.
Follow-up: A partial dose because the pen emptied mid-injection Replied, post #8 · Practice › Administration · 23 Jul 2024 · 23 likes No notes. Posting so the count is not one.
Journal club: FLOW and the renal composite, component by component Replied, post #18 · Evidence › Journal club · 10 Jul 2024 · 20 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.
Coming back to: Preparing for an appointment: one page, three questions Replied, post #3 · Clinical › Prescriber conversations · 5 Jun 2024 · 8 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. I have seen it go both ways, which is why I hedge.